APA Zitierstil

Scilla, K. A., Bentzen, S. M., Lam, V. K., Mohindra, P., Nichols, E. M., Vyfhuis, M. A., . . . Feliciano, J. L. (2017). Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy. Oncologist.

Chicago Zitierstil

Scilla, Katherine A., et al. "Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients With Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated With Combined Modality Therapy." Oncologist 2017.

MLA Zitierstil

Scilla, Katherine A., et al. "Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients With Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated With Combined Modality Therapy." Oncologist 2017.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.